Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.42 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.42 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | NRP1 | O14786 | 2/20 | 0.41 |
| ▸ | F2 | P00734 | 5/20 | 0.39 |
| ▸ | MASP2 | O00187 | 3/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.36 |
| ▸ | NPY1R | P25929 | 2/20 | 0.36 |
| ▸ | NPY4R | P50391 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30416888 | 0.93 | MAPK8 (0.42) | PRCPMEN1KMT2AMAPK8MAPK9 | |
| SCHEMBL29663559 | 0.93 | MAPK8 (0.46) | PRCPMAPK8MAPK9MAPK10NPY5R | |
| SCHEMBL30193454 | 0.92 | PRCP (0.44) | PRCPMEN1KMT2AMAPK8MAPK9 | |
| SCHEMBL29687469 | 0.92 | MAPK8 (0.48) | MEN1KMT2AMAPK8MAPK9MAPK10 | |
| SCHEMBL29824904 | 0.91 | MEN1 (0.41) | PRCPMEN1KMT2AMAPK8MAPK9 | |
| SCHEMBL29496543 | 0.91 | MEN1 (0.44) | PRCPMEN1KMT2AMAPK8MAPK9 | |
| SCHEMBL17711236 | 0.90 | MEN1 (0.47) | PRCPMEN1KMT2AMAPK8MAPK9 | |
| SCHEMBL31487414 | 0.90 | MEN1 (0.47) | PRCPMEN1KMT2AMAPK8MAPK9 | |
| SCHEMBL8759336 | 0.90 | MEN1 (0.47) | PRCPMEN1KMT2AMAPK8MAPK9 | |
| SCHEMBL8759341 | 0.90 | MEN1 (0.47) | PRCPMEN1KMT2AMAPK8MAPK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4388311-B1 | METHODS COMPRISING THERAPEUTIC COMPOUNDS AND IN VITRO MAMMALIAN SKIN | AMGEN INC (US) | 2025-10-15 | — | — | EP | claimed |
| CN-112159461-B | Synthesis method of cetrorelix | 开封明仁药业有限公司 | 2023-03-10 | — | — | CN | disclosed |
| EP-3969467-A2 | VARIANT SINGLE-CHAIN INSULIN ANALOGUES | CASE WESTERN RESERVE UNIVERSITY (US) | 2022-03-23 | — | — | EP | disclosed |